238 related articles for article (PubMed ID: 8091435)
21. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
Malinow MR
J Nutr; 1996 Apr; 126(4 Suppl):1238S-43S. PubMed ID: 8642463
[TBL] [Abstract][Full Text] [Related]
22. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
23. Association between homocyst(e)ine levels and risk of vascular events.
Kaplan ED
Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Yoo JH; Lee SC
Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress in the context of acute cerebrovascular stroke.
El Kossi MM; Zakhary MM
Stroke; 2000 Aug; 31(8):1889-92. PubMed ID: 10926952
[TBL] [Abstract][Full Text] [Related]
26. High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage.
Kario K; Duell PB; Matsuo T; Sakata T; Kato H; Shimada K; Miyata T
Atherosclerosis; 2001 Aug; 157(2):441-9. PubMed ID: 11472745
[TBL] [Abstract][Full Text] [Related]
27. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and ischaemic heart disease in the Caerphilly cohort.
Ubbink JB; Fehily AM; Pickering J; Elwood PC; Vermaak WJ
Atherosclerosis; 1998 Oct; 140(2):349-56. PubMed ID: 9862278
[TBL] [Abstract][Full Text] [Related]
29. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
Malinow MR; Nieto FJ; Szklo M; Chambless LE; Bond G
Circulation; 1993 Apr; 87(4):1107-13. PubMed ID: 8462139
[TBL] [Abstract][Full Text] [Related]
30. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
von Eckardstein A; Malinow MR; Upson B; Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
Arterioscler Thromb; 1994 Mar; 14(3):460-4. PubMed ID: 8123652
[TBL] [Abstract][Full Text] [Related]
31. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults.
Shimakawa T; Nieto FJ; Malinow MR; Chambless LE; Schreiner PJ; Szklo M
Ann Epidemiol; 1997 May; 7(4):285-93. PubMed ID: 9177112
[TBL] [Abstract][Full Text] [Related]
32. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
Spence JD
Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
[TBL] [Abstract][Full Text] [Related]
33. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria.
Mansoor MA; Ueland PM; Aarsland A; Svardal AM
Metabolism; 1993 Nov; 42(11):1481-5. PubMed ID: 8231845
[TBL] [Abstract][Full Text] [Related]
34. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
Kang SS; Wong PW; Cook HY; Norusis M; Messer JV
J Clin Invest; 1986 May; 77(5):1482-6. PubMed ID: 3700650
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease.
Genest JJ; McNamara JR; Upson B; Salem DN; Ordovas JM; Schaefer EJ; Malinow MR
Arterioscler Thromb; 1991; 11(5):1129-36. PubMed ID: 1911700
[TBL] [Abstract][Full Text] [Related]
36. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
37. Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum.
Rajkovic A; Mahomed K; Malinow MR; Sorenson TK; Woelk GB; Williams MA
Obstet Gynecol; 1999 Sep; 94(3):355-60. PubMed ID: 10472859
[TBL] [Abstract][Full Text] [Related]
38. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial.
Evans RW; Shaten BJ; Hempel JD; Cutler JA; Kuller LH;
Indian Heart J; 2000; 52(7 Suppl):S44-52. PubMed ID: 11339440
[TBL] [Abstract][Full Text] [Related]
39. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.
Ford ES; Smith SJ; Stroup DF; Steinberg KK; Mueller PW; Thacker SB
Int J Epidemiol; 2002 Feb; 31(1):59-70. PubMed ID: 11914295
[TBL] [Abstract][Full Text] [Related]
40. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
